vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and Smith Douglas Homes Corp. (SDHC). Click either name above to swap in a different company.
Smith Douglas Homes Corp. is the larger business by last-quarter revenue ($260.4M vs $208.9M, roughly 1.2× iRhythm Holdings, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs 1.4%, a 1.3% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -9.4%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $8.7M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 17.3%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
IRTC vs SDHC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $260.4M |
| Net Profit | $5.6M | $3.5M |
| Gross Margin | 70.9% | 19.9% |
| Operating Margin | 1.1% | 6.5% |
| Net Margin | 2.7% | 1.4% |
| Revenue YoY | 27.1% | -9.4% |
| Net Profit YoY | 518.5% | -14.3% |
| EPS (diluted) | $0.18 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $260.4M | ||
| Q3 25 | $192.9M | $262.0M | ||
| Q2 25 | $186.7M | $223.9M | ||
| Q1 25 | $158.7M | $224.7M | ||
| Q4 24 | $164.3M | $287.5M | ||
| Q3 24 | $147.5M | $277.8M | ||
| Q2 24 | $148.0M | $220.9M | ||
| Q1 24 | $131.9M | $189.2M |
| Q4 25 | $5.6M | $3.5M | ||
| Q3 25 | $-5.2M | $2.1M | ||
| Q2 25 | $-14.2M | $2.4M | ||
| Q1 25 | $-30.7M | $2.7M | ||
| Q4 24 | $-1.3M | $4.1M | ||
| Q3 24 | $-46.2M | $5.3M | ||
| Q2 24 | $-20.1M | $3.6M | ||
| Q1 24 | $-45.7M | $3.0M |
| Q4 25 | 70.9% | 19.9% | ||
| Q3 25 | 71.1% | 21.0% | ||
| Q2 25 | 71.2% | 23.2% | ||
| Q1 25 | 68.8% | 23.8% | ||
| Q4 24 | 70.0% | 25.5% | ||
| Q3 24 | 68.8% | 26.5% | ||
| Q2 24 | 69.9% | 26.7% | ||
| Q1 24 | 66.3% | 26.1% |
| Q4 25 | 1.1% | 6.5% | ||
| Q3 25 | -4.4% | 6.6% | ||
| Q2 25 | -10.0% | 7.7% | ||
| Q1 25 | -20.5% | 8.7% | ||
| Q4 24 | -2.5% | 10.4% | ||
| Q3 24 | -34.1% | 14.2% | ||
| Q2 24 | -15.5% | 11.7% | ||
| Q1 24 | -28.9% | 11.3% |
| Q4 25 | 2.7% | 1.4% | ||
| Q3 25 | -2.7% | 0.8% | ||
| Q2 25 | -7.6% | 1.1% | ||
| Q1 25 | -19.3% | 1.2% | ||
| Q4 24 | -0.8% | 1.4% | ||
| Q3 24 | -31.3% | 1.9% | ||
| Q2 24 | -13.6% | 1.7% | ||
| Q1 24 | -34.6% | 1.6% |
| Q4 25 | $0.18 | $0.39 | ||
| Q3 25 | $-0.16 | $0.24 | ||
| Q2 25 | $-0.44 | $0.26 | ||
| Q1 25 | $-0.97 | $0.30 | ||
| Q4 24 | $-0.03 | $0.50 | ||
| Q3 24 | $-1.48 | $0.58 | ||
| Q2 24 | $-0.65 | $0.40 | ||
| Q1 24 | $-1.47 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $12.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $86.7M |
| Total Assets | $1.0B | $557.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $12.7M | ||
| Q3 25 | $565.2M | $14.8M | ||
| Q2 25 | $545.5M | $16.8M | ||
| Q1 25 | $520.6M | $12.7M | ||
| Q4 24 | $535.6M | $22.4M | ||
| Q3 24 | $522.0M | $23.7M | ||
| Q2 24 | $561.5M | $17.3M | ||
| Q1 24 | $569.1M | $32.8M |
| Q4 25 | $152.7M | $86.7M | ||
| Q3 25 | $121.9M | $82.2M | ||
| Q2 25 | $103.7M | $80.0M | ||
| Q1 25 | $86.7M | $76.9M | ||
| Q4 24 | $90.9M | $73.6M | ||
| Q3 24 | $71.8M | $68.4M | ||
| Q2 24 | $99.2M | $62.1M | ||
| Q1 24 | $90.3M | $59.7M |
| Q4 25 | $1.0B | $557.6M | ||
| Q3 25 | $995.2M | $571.6M | ||
| Q2 25 | $964.0M | $570.2M | ||
| Q1 25 | $926.1M | $513.9M | ||
| Q4 24 | $931.4M | $475.9M | ||
| Q3 24 | $909.7M | $460.1M | ||
| Q2 24 | $919.2M | $429.3M | ||
| Q1 24 | $909.8M | $401.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $9.8M |
| Free Cash FlowOCF − Capex | $14.5M | $8.7M |
| FCF MarginFCF / Revenue | 6.9% | 3.4% |
| Capex IntensityCapex / Revenue | 5.6% | 0.4% |
| Cash ConversionOCF / Net Profit | 4.70× | 2.77× |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $-36.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $9.8M | ||
| Q3 25 | $34.9M | $22.8M | ||
| Q2 25 | $27.7M | $-28.9M | ||
| Q1 25 | $-7.9M | $-34.9M | ||
| Q4 24 | $19.2M | $5.5M | ||
| Q3 24 | $24.3M | $22.9M | ||
| Q2 24 | $11.8M | $39.0K | ||
| Q1 24 | $-52.0M | $-9.3M |
| Q4 25 | $14.5M | $8.7M | ||
| Q3 25 | $20.1M | $21.4M | ||
| Q2 25 | $17.3M | $-31.1M | ||
| Q1 25 | $-17.3M | $-35.9M | ||
| Q4 24 | $12.4M | $4.8M | ||
| Q3 24 | $15.5M | $22.3M | ||
| Q2 24 | $3.4M | $-2.1M | ||
| Q1 24 | $-61.8M | $-9.7M |
| Q4 25 | 6.9% | 3.4% | ||
| Q3 25 | 10.4% | 8.2% | ||
| Q2 25 | 9.3% | -13.9% | ||
| Q1 25 | -10.9% | -16.0% | ||
| Q4 24 | 7.5% | 1.7% | ||
| Q3 24 | 10.5% | 8.0% | ||
| Q2 24 | 2.3% | -1.0% | ||
| Q1 24 | -46.8% | -5.1% |
| Q4 25 | 5.6% | 0.4% | ||
| Q3 25 | 7.7% | 0.5% | ||
| Q2 25 | 5.6% | 0.9% | ||
| Q1 25 | 5.9% | 0.5% | ||
| Q4 24 | 4.2% | 0.2% | ||
| Q3 24 | 6.0% | 0.2% | ||
| Q2 24 | 5.7% | 1.0% | ||
| Q1 24 | 7.4% | 0.2% |
| Q4 25 | 4.70× | 2.77× | ||
| Q3 25 | — | 10.70× | ||
| Q2 25 | — | -12.24× | ||
| Q1 25 | — | -13.01× | ||
| Q4 24 | — | 1.33× | ||
| Q3 24 | — | 4.28× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | — | -3.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
SDHC
| Southeast | $164.7M | 63% |
| Central | $95.8M | 37% |
